# CJ CheilJedang Grapples with Financial Improvement Amid Declining Performance and Asset Sales - 한국금융신문

> CJ CheilJedang's third-quarter bio division revenue fell 8.4% and operating profit fell 71.9%, driven by competition in tryptophan, arginine and nucleic acids and weak lysine conditions in Europe. The company is divesting non-core businesses to improve finances.

- Date: 2025-12-22 · published 2025-12-22T12:00:00.000Z
- Category: market · region Global · magnitude low
- Page: https://feedsoft.ai/events/21848-cj-cheiljedang-grapples-with-financial-improvement-amid-declining-performance
- Commodities: [Lysine](https://feedsoft.ai/c/LYSINE.md)

## Why it matters

Weak lysine margins and intense competition signal oversupply in amino acids, which keeps feed additive prices under pressure.

## Read by commodity

- LYSINE: bearish ▼

## Sources

- fntimes.com: https://www.fntimes.com/html/view.php?ud=202512220859519169141825007d_18

---
Data from Feedsoft AI (https://feedsoft.ai/). For information only; not investment advice.